The US Supreme Court will examine whether companies should be able to patent human genes they have isolated and identified. This is a decision that could have far-reaching implications for genetic research. An appeals court in August authorized a biotechnology company, Myriad Genetics Inc, to patent two genes it found had links to breast and ovarian cancer -- women with the gene were at a much higher risk of developing the cancers. These ...Sunday, 2 December 2012
Ruling Awaited on Whether Companies can Patent Genes
The US Supreme Court will examine whether companies should be able to patent human genes they have isolated and identified. This is a decision that could have far-reaching implications for genetic research. An appeals court in August authorized a biotechnology company, Myriad Genetics Inc, to patent two genes it found had links to breast and ovarian cancer -- women with the gene were at a much higher risk of developing the cancers. These ...
Labels:
Health News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment